European Commission authorises ViiV Healthcare Vocabria plus Rekambys for HIV treatment in adolescents Ruchika Sharma2 Feb 2025 1:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
Lupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension for HIV-1 infection Ruchika Sharma24 Jan 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin bags tentative USFDA okay for Abacavir, Dolutegravir, Lamivudine Tablets for Oral Suspension for HIV treatment Ruchika Sharma6 Dec 2024 2:56 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
HIV-1 injectable treatment: GSK's ViiV Healthcare gets Chinese nod for Vocabria used in combination with Rekambys Ruchika Sharma26 Oct 2023 4:21 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as...
GSK HIV prevention drug gets European Commission authorisation Ruchika Sharma19 Sept 2023 2:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
Strides Pharma Science Singapore arm secures USFDA tentative okay for HIV drug Dolutegravir Ruchika Sharma15 Sept 2023 11:32 AM ISTThis medication is the first line of antiretroval therapy for treatment naïve patients.
Viatris gets USFDA tentative nod for paediatric formulation of Abacavir, Dolutegravir, Lamivudine for children with HIV Ruchika Sharma5 Sept 2023 3:54 PM ISTBangalore: Viatris Inc., a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug...
USFDA tentative nod to Aurobindo Pharma's generic FDC drug to treat HIV in children Ruchika Sharma17 Aug 2023 1:30 PM ISTAurobindo has capacities in their FDA approved plant to meet the market demand for this product and commercial production will commence in Q3 FY24.
Lupin Dolutegravir Tablets for Oral Suspension gets tentative USFDA nod for HIV/AIDS Ruchika Sharma4 July 2023 5:38 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration...
Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
Lupin bags USFDA nod for Dolutegravir, Rilpivirine tablets to treat HIV infection Ruchika Sharma16 Jan 2023 3:20 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration...
ViiV Healthcare Cabotegravir long-acting injectable for HIV prevention gets EMA validation Ruchika Sharma30 Oct 2022 11:45 AM ISTCabotegravir long-acting for PrEP is an integrase strand transfer inhibitor (INSTI).
